Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1087 clinical trials
Effects of Barley Green in Patients With Hyperuricemia

This experiment evaluates the effect of Barley Green in patients with hyperuricemia and explores the effect of Barley Green on metabolic indexes such as uric acid, blood lipids, blood glucose, free fatty acids130 adult participants , age 18 to 65 years, will be randomized into one of the two arms.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Culturally Centered CBT for Latinx Youth

The primary aim of the proposed research is to test the effect of a culturally centered treatment protocol, the Socio-cognitive behavioral therapy (SCBT), versus Treatment as Usual on suicidal thoughts and attempts, and depressive symptoms, in a clinical sample of Latinx adolescents. The study is trying to determine, if we …

behavior therapy
depressive symptoms
suicide
cognitive therapy
suicidal
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Effect of Quercetin on Prophylaxis and Treatment of COVID-19

It's known that COVID-19 goes with excessive immune reaction of human body in severe cases. The investigators hypothesize that quercetin, as a strong scavenger and anti-inflammatory agent, can be effective on both prophylaxis and treatment of COVID-19 cases. Therefore, the aim of this study to evaluate the possible role of …

coronavirus infection
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tactile Low Vision Labeling of Ophthalmic Drops

The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch (UTMB) in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency …

  • 0 views
  • 19 Feb, 2024
  • 1 location
ADME Study of Acoziborole in Healthy Subjects

All subjects will receive an oral dose of 960 mg [14C] acoziborole on a single occasion as 4 capsules containing a small amount of radioactivity (not more than [NMT] 1000 nCi [37 KBq] 14C).

  • 0 views
  • 19 Feb, 2024
  • 1 location
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma

This is a prospective, open-labelled study to evaluate the efficacy and safety of camrelizumab combined with apatinib mesylate in the induction treatment of patients with locally advanced head and neck squamous cell carcinoma who were judged surgically unresectable or appropriate for non-surgical definitive therapy. The objective response rate (ORR) and …

white blood cell count
definitive treatment
measurable disease
locally advanced head and neck squamous cell carcinoma
caries
  • 0 views
  • 19 Feb, 2024
  • 1 location
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

This first-in-human (FIH) study has been designed to evaluate the safety, tolerability, and preliminary antitumor activity of TTX-080 as monotherapy in adults with unresectable or metastatic solid tumors known to express HLA-G.

hla-g
cancer
metastasis
solid tumour
measurable disease
  • 0 views
  • 19 Feb, 2024
  • 2 locations
BrainWeighve App Feasibility Study- Fahima  

As research within the field of mHealth has grown, technology-based interventions have gained traction, specifically interactive smartphone applications (apps).

Accepts healthy volunteers
  • 0 views
  • 24 Apr, 2026
  • 1 location
Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

This a phase 2 study that aims to determine the pathological complete response of the combination of stereotactic ablative radiotherapy (SABR) plus nivolumab as neoadjuvant treatment in early-stage non-small cell lung cancer. The patients will receive standard SABR + nivolumab at a dose of 360 mg every 21 days for …

pet/ct scan
immunosuppressive agents
small cell lung cancer
tubal ligation
pulmonary function test
  • 0 views
  • 19 Feb, 2024
  • 1 location
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

This pilot trial studies how well leflunomide works for the treatment of patients with high-risk smoldering plasma cell myeloma, for the delay of disease progression. Anti-inflammatory drugs, such as leflunomide lower the body's immune response and are used with other drugs in the treatment of some types of cancer. The …

smoldering multiple myeloma
spot test
beta-human chorionic gonadotropin
hepatitis
smoldering myeloma
  • 0 views
  • 19 Feb, 2024
  • 1 location